Found: 32
Select item for more details and to access through your institution.
Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2378, doi. 10.1111/bjh.19451
- By:
- Publication type:
- Article
A predictive model combining clinical characteristics and nutritional risk factors for overall survival after umbilical cord blood transplantation.
- Published in:
- Stem Cell Research & Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13287-023-03538-7
- By:
- Publication type:
- Article
Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real‐world experience of a referral center.
- Published in:
- EJHaem, 2023, v. 4, n. 2, p. 470, doi. 10.1002/jha2.703
- By:
- Publication type:
- Article
High-dose cytarabine monotherapy is superior to standard-dose cytarabine-based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1070588
- By:
- Publication type:
- Article
Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-03186-3
- By:
- Publication type:
- Article
The clinical influence of preformed nonspecific anti‐HLA antibodies on single‐unit umbilical cord blood transplantation in patients with haematological malignancies.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. e63, doi. 10.1111/bjh.18316
- By:
- Publication type:
- Article
Allogeneic double‐negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first‐in‐human phase I study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E264, doi. 10.1002/ajh.26564
- By:
- Publication type:
- Article
Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine‐busulfan‐cyclophosphamide‐based conditioning.
- Published in:
- Pediatric Transplantation, 2022, v. 26, n. 2, p. 1, doi. 10.1111/petr.14181
- By:
- Publication type:
- Article
Poor survival and prediction of prolonged isolated thrombocytopenia post umbilical cord blood transplantation in patients with hematological malignancies.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 82, doi. 10.1002/hon.2937
- By:
- Publication type:
- Article
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
- Published in:
- Clinical Interventions in Aging, 2022, v. 17, p. 55, doi. 10.2147/CIA.S343598
- By:
- Publication type:
- Article
Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.025
- By:
- Publication type:
- Article
Umbilical cord blood transplantation: Still growing and improving.
- Published in:
- Stem Cells Translational Medicine, 2021, v. 10, p. S62, doi. 10.1002/sctm.20-0495
- By:
- Publication type:
- Article
Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 5, p. 569, doi. 10.1159/000507973
- By:
- Publication type:
- Article
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen.
- Published in:
- International Journal of Hematology, 2021, v. 114, n. 3, p. 381, doi. 10.1007/s12185-021-03168-w
- By:
- Publication type:
- Article
Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24412-1
- By:
- Publication type:
- Article
Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 5, p. 1303, doi. 10.1007/s00277-021-04413-2
- By:
- Publication type:
- Article
All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-021-00411-9
- By:
- Publication type:
- Article
Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.005
- By:
- Publication type:
- Article
Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1372, doi. 10.1111/jcpt.13231
- By:
- Publication type:
- Article
Pretreatment of unrelated umbilical cord blood transplantation without antithymocyte globulin for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia: follow-up evaluation of 306 cases.
- Published in:
- Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2020, v. 24, n. 31, p. 4986, doi. 10.3969/j.issn.2095-4344.2141
- By:
- Publication type:
- Article
Effects and long‐term follow‐up of using umbilical cord blood–derived mesenchymal stromal cells in pediatric patients with severe BK virus‐associated late‐onset hemorrhagic cystitis after unrelated cord blood transplantation.
- Published in:
- Pediatric Transplantation, 2020, v. 24, n. 2, p. 1, doi. 10.1111/petr.13618
- By:
- Publication type:
- Article
Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 109/L.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 9495, doi. 10.2147/CMAR.S225123
- By:
- Publication type:
- Article
Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease.
- Published in:
- Infection & Drug Resistance, 2019, v. 12, p. 481, doi. 10.2147/IDR.S191462
- By:
- Publication type:
- Article
The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 3, p. 699, doi. 10.1002/ijc.31339
- By:
- Publication type:
- Article
Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia.
- Published in:
- Pediatric Transplantation, 2016, v. 20, n. 8, p. 1117, doi. 10.1111/petr.12805
- By:
- Publication type:
- Article
A comparative study of idarubicin 12 mg/m<sup>2</sup> and 8 mg/m<sup>2</sup> combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 985, doi. 10.2147/OTT.S96176
- By:
- Publication type:
- Article
Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 3, p. 473, doi. 10.1007/s00277-014-2213-y
- By:
- Publication type:
- Article
Unrelated cord blood transplantation for central nervous system relapse in high-risk childhood acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 12, p. 1665, doi. 10.1007/s00277-013-1820-3
- By:
- Publication type:
- Article
Successful second transplantation with non-myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation.
- Published in:
- Pediatric Transplantation, 2010, v. 14, n. 4, p. 465, doi. 10.1111/j.1399-3046.2009.01231.x
- By:
- Publication type:
- Article